Analyst Ratings published Wednesday September 17th 2025

9/17/25	Upgrades	Hold Buy	X
ABBV AbbVie Berenberg
$270
9/17/25	Downgrades	Buy Neutral	X
AMH American Homes 4 Rent Goldman
$37
9/17/25	Reiterated	Buy	X
AON Aon TD Cowen
$427 $419
9/17/25	Resumed	Overweight	X
ARVN Arvinas Barclays
$16
9/17/25	Initiated	Overweight	X
AVNT Avient KeyBanc Capital Markets
$48
9/17/25	Initiated	Buy	X
BHVN Biohaven Citigroup
$28
9/17/25	Initiated	Overweight	X
CCCC C4 Therapeutics Barclays
$8
9/17/25	Downgrades	Neutral Sell	X
CPT Camden Property Goldman
$106
9/17/25	Resumed	Overweight	X
CTMX CytomX Therapeutics Barclays
$3.50
9/17/25	Resumed	Equal Weight	X
EXEL Exelixis Barclays
$40
9/17/25	Initiated	Buy	X
EXEL Exelixis Goldman
$47
9/17/25	Downgrades	Outperform In-line	X
FDX FedEx Evercore ISI
$243
9/17/25	Resumed	Buy	X
FHTX Foghorn Therapeutics B. Riley Securities
$10
9/17/25	Initiated	Mkt Perform	X
FIVE Five Below Bernstein
$160
9/17/25	Downgrades	Buy Hold	X
GRAB Grab HSBC Securities
$6.20
9/17/25	Downgrades	Overweight Eq-Weight	X
HAIN Hain Celestial Stephens
$2
9/17/25	Initiated	Outperform	X
HGTY Hagerty Oppenheimer
$15
9/17/25	Initiated	Overweight	X
JANX Janux Therapeutics Barclays
$47
9/17/25	Upgrades	Neutral Buy	X
KR Kroger Roth Capital
$75
9/17/25	Upgrades	Sec Underperform Sec Perform	X
KRC Kilroy Realty Scotiabank
$47
9/17/25	Initiated	Overweight	X
KYMR Kymera Therapeutics Barclays
$60
9/17/25	Downgrades	Buy Hold	X
LLY Eli Lilly Berenberg
$830
9/17/25	Resumed	Overweight	X
MGNX MacroGenics Barclays
$3
9/17/25	Downgrades	Buy Hold	X
MRK Merck Berenberg
$90
9/17/25	Initiated	Overweight	X
MRUS Merus Barclays
$112
9/17/25	Upgrades	Peer Perform Outperform	X
MTZ MasTec Wolfe Research
$227
9/17/25	Upgrades	Hold Buy	X
NFLX Netflix Loop Capital
$1350
9/17/25	Upgrades	Hold Buy	X
NVO Novo Nordisk A/S Berenberg
9/17/25	Upgrades	Neutral Overweight	X
ORA Ormat Tech Piper Sandler
$102
9/17/25	Downgrades	Outperform Mkt Perform	X
PGR Progressive BMO Capital Markets
$250
9/17/25	Initiated	Overweight	X
PTGX Protagonist Therapeutics Barclays
$72
9/17/25	Reiterated	Outperform	X
RL Ralph Lauren Telsey Advisory Group
$335 $350
9/17/25	Initiated	Buy	X
RNA Avidity Biosciences Roth Capital
$62
9/17/25	Upgrades	Eq Weight Overweight	X
RYAN Ryan Specialty Group Wells Fargo
$60
9/17/25	Initiated	Underweight	X
SMMT Summit Therapeutics Barclays
$13
9/17/25	Initiated	Overweight	X
SRRK Scholar Rock Barclays
$45
9/17/25	Reiterated	Buy	X
TDG Transdigm Group Jefferies
$1650 $1490
9/17/25	Initiated	Overweight	X
TERN Terns Pharmaceuticals Barclays
$15
9/17/25	Downgrades	Mkt Outperform Mkt Perform	X
TRTX TPG RE Finance Trust Citizens JMP
9/17/25	Downgrades	Overweight Neutral	X
TS Tenaris Piper Sandler
$41
9/17/25	Downgrades	Buy Neutral	X
VCEL Vericel BTIG Research
9/17/25	Upgrades	Neutral Buy	X
VST Vistra Corp. Daiwa Securities
$250
9/17/25	Upgrades	Hold Buy	X
VTEX VTEX Jefferies
$6.50
9/17/25	Upgrades	Neutral Buy	X
WDAY Workday Guggenheim
$285
9/17/25	Upgrades	Underweight Neutral	X
WDAY Workday Piper Sandler
$235
9/17/25	Resumed	Underweight	X
XNCR Xencor Barclays
$6
9/17/25	Upgrades	Mkt Perform Outperform	X
Z Zillow C Bernstein
$105
9/17/25	Upgrades	Mkt Perform Outperform	X
ZG Zillow Bernstein